首页>The Journal of dermatological treatment>Dose increase beyond labelled dose of biologics is associated with incremental pharmacy costs: results from a real-world study in the UK
Dose increase beyond labelled dose of biologics is associated with incremental pharmacy costs: results from a real-world study in the UK